The cancer stem cell microenvironment and anti-cancer therapy Cancer stem cells and therapy

International Journal of Radiation Biology

Volumn 85, Issue 11, 2009, Pages 955-962

  Ghotra, Veerander P S ^a   Puigvert, Jordi C ^a,b   Danen, Erik H J ^a  

^a LEIDEN UNIVERSITY   (Netherlands)

^b Netherlands Toxicogenomics Center   (Netherlands)

Author keywords

Chemotherapy; Radiotherapy; Stem cells

Indexed keywords

ABC TRANSPORTER; MULTIDRUG RESISTANCE PROTEIN;

CANCER CHEMOTHERAPY; CANCER GROWTH; CANCER RADIOTHERAPY; CANCER STEM CELL; CANCER THERAPY; CELL POPULATION; CYTOLOGY; DNA DAMAGE; DNA REPAIR; HUMAN; MICROENVIRONMENT; NONHUMAN; PRIORITY JOURNAL; REVIEW;

ANIMALS; ATP-BINDING CASSETTE TRANSPORTERS; DNA REPAIR; DRUG RESISTANCE, NEOPLASM; G0 PHASE; HUMANS; MODELS, BIOLOGICAL; NEOPLASTIC STEM CELLS; RADIATION TOLERANCE; REACTIVE OXYGEN SPECIES;

EID: 70449492809     PISSN: 09553002     EISSN: 13623095     Source Type: Journal    
DOI: 10.3109/09553000903242164     Document Type: Review

References (78)

1. Adams GB, Scadden DT. 2008. A niche opportunity for stem cell therapeutics. Gene Therapy 15(2):96-99.
2. Al-Hajj M, Wicha MS, Benito-Hernandez A, Morrison SJ, Clarke MF. 2003. Prospective identification of tumorigenic breast cancer cells. Proceedings of the National Academy of Science USA 100(7):3983-3988. (Pubitemid 36418143)
3. Bao S, Wu Q, McLendon RE, Hao Y, Shi Q, Hjelmeland AB, Dewhirst MW, Bigner DD, Rich JN. 2006. Glioma stem cells promote radioresistance by preferential activation of the DNA damage response. Nature 444(7120):756-760.
4. Batchelor TT, Sorensen AG, di Tomaso E, Zhang WT, Duda DG, Cohen KS, Kozak KR, Cahill DP, Chen PJ, Zhu M, Ancukiewicz M, Mrugala MM, Plotkin S, Drappatz J, Louis DN, Ivy P, Scadden DT, Benner T, Loeffler JS, Wen PY, Jain RK. 2007. AZD2171, a pan-VEGF receptor tyrosine kinase inhibitor, normalizes tumor vasculature and alleviates edema in glioblastoma patients. Cancer Cell 11(1):83-95.
5. BaumannM, Krause M, Hill R. 2008. Exploring the role of cancer stem cells in radioresistance. Nature Reviews Cancer 8(7): 545-554.
6. Calabrese C, Poppleton H, Kocak M, Hogg TL, Fuller C, Hamner B, Oh EY, Gaber MW, Finklestein D, AllenM, Frank A, Bayazitov IT, Zakharenko SS, Gajjar A, Davidoff A, Gilbertson RJ. 2007. A perivascular niche for brain tumor stem cells. Cancer Cell 11(1):69-82.
7. Calvi LM, Adams GB, Weibrecht KW, Weber JM, Olson DP, Knight MC, Martin RP, Schipani E, Divieti P, Bringhurst FR, Milner LA, Kronenberg HM, Scadden DT. 2003. Osteoblastic cells regulate the haematopoietic stem cell niche. Nature 425(6960):841-846.
8. Carmeliet P. 2003. Blood vessels and nerves: common signals, pathways and diseases. Nature Reviews Genetics 4(9):710-720.
9. Clarke MF, Dick JE, Dirks PB, Eaves CJ, Jamieson CHM, Leane Jones D, Visvader J, Weissman IL, Wahl GM. 2006. Cancer Stem Cells-Perspectives on current status and future directions. Cancer Research 66(19).
10. Clarke MF, Fuller M. 2006. Stem cells and cancer: two faces of eve. Cell 124(6):1111-1115.
11. Cleaver O, Melton DA. 2003. Endothelial signaling during development. Nature Medicine 9(6):661-668.
12. Dalerba P, Cho RW, Clarke MF. 2008. Cancer stem cells: models and concepts. Stem Cells 1:267-284.
13. De Toni F, Racaud-Sultan C, Chicanne G, Mas VM, Cariven C, Mesange F, Salles JP, Demur C, Allouche M, Payrastre B, Manenti S, Ysebaert L. 2006. A crosstalk between the Wnt and the adhesion-dependent signaling pathways governs the chemosensitivity of acute myeloid leukemia. Oncogene 25(22): 3113-3122.
14. Dean M. 2009. ABC transporters, drug resistance, and cancer stem cells. Journal of Mammary Gland Biology and Neoplasia 14:3-9.
15. Deng W, Lin H. 1997. Spectrosomes and fusomes anchor mitotic spindles during asymmetric germ cell divisions and facilitate the formation of a polarized microtubule array for oocyte specification in Drosophila. Developmental Biology 189(1): 79-94.
16. Diehn M, Cho RW, Lobo NA, Kalisky T, Dorie MJ, Kulp AN, Qian D, Lam JS, Ailles LE, Wong M, Joshua B, Kaplan MJ, Wapnir I, Dirbas FM, Somlo G, Garberoglio C, Paz B, Shen J, Lau SK, Quake SR, Brown JM, Weissman IL, Clarke MF. 2009. Association of reactive oxygen species levels and radioresistance in cancer stem cells. Nature 458(7239):780-783.
17. Doetsch F, Caillé I, Lim DA, Garc?́a-Verdugo JM, Alvarez- Buylla A. 1999. Subventricular zone astrocytes are neural stem cells in the adult mammalian brain. Cell 97(6):703-716.
18. Eyler CE, Rich JN. 2008. Survival of the fittest: Cancer stem cells in therapeutic resistance and angiogenesis. Journal of Clinical Oncology 26(17):2839-2845.
19. Folkins C, Man S, Xu P, Shaked Y, Hicklin DJ, Kerbel RS. 2007. Anticancer therapies combining antiangiogenic and tumor cell cytotoxic effects reduce the tumor stem-like cell fraction in glioma xenograft tumors. Cancer Research 67(8):3560-3564.
20. Fuchs E, Segre JA. 2000. Stem cells: a new lease on life. Cell 100: 143-155.
21. Fuchs E, Tumbar T, Guasch G. 2004. Socializing with the neighbors: Stem cells and their niche. Cell 166(6):769-778.
22. Gerson SL, Reese J, Kenyon J. 2007. DNA repair in stem cell maintenance and conversion to cancer stem cells. Ernst Schering Foundation Symposium Proceedings (5):231-244.
23. Gilbertson RJ, Rich JN. 2007. Making a tumor's bed: Glioblastoma stem cells and the vascular niche. Nature Reviews Cancer 7(10):733-736.
24. Hambardzumyan D, Becher OJ, Rosenblum MK, Pandolfi PP, Manova-Todorova K, Holland EC. 2008. PI3K pathway regulates survival of cancer stem cells residing in the perivascular niche following radiation in medulloblastoma in vivo. Genes & Development 22(4):436-448.
25. Henderson ST, Gao D, Lambie EJ, Kimble J. 1994. Lag-2 may encode a signaling ligand for the GLP-1 and LIN-12 receptors of Cflelegans. Development 120(10):2913-2924.
26. Hess C, Vuong V, Hegyi I, Riesterer O, Wood J, Fabbro D, Glanzmann C, Bodis S, Pruschy M. 2001. Effect of VEGF receptor inhibitor PTK787/ZK222584 combined with ionizing radiation on endothelial cells and tumor growth. British Journal of Cancer 85(12):2010-2016.
27. Hirschmann-Jax C, Foster AE, Wulf GG, Nuchtern JG, Jax TW, Gobel U, Goodell MW, Brenner MK. 2004. A distinct 'side population' of cells with high drug efflux capacity in human tumor cells. Proceedings of the National Academy of Science USA 101(39):14228-14233.
28. Ishikawa F, Yoshida S, Saito Y, Hijikata A, Kitamura H, Tanaka S, Nakamura R, Tanaka T, Tomiyama H, Saito N, Fukata M, Miyamoto T, Lyons B, Ohshima K, Uchida N, Taniguchi S, Ohara O, Akashi K, Harada M, Shultz LD. 2007. Chemotherapy resistant human AML stem cells home to and engraft within the bone marrow endosteal region. Nature Biotechnology 25(11):1315-1321.
29. Ito K, Hirao A, Arai F, Matsuoka S, Takubo K, Hamaguchi I, Nomiyama K, Hosokawa K, Sakurada K, Nakagata N, Ikeda Y, Mak TW, Suda T. 2004. Regulation of oxidative stress by ATM is required for self-renewal of haematopoietic stem cells. Nature 431(7011):997-1002.
30. Ito K, Hirao A, Arai F, Takubo K, Matsuoka S, Miyamoto K, Ohmura M, Naka K, Hosokawa K, Ikeda Y, Suda T. 2006. Reactive oxygen species act through p38 MAPK to limit the lifespan of hematopoietic stem cells. Nature Medicine 12(4): 446-451.
31. Jin L, Hope KJ, Zhai Q, Smadja-Joffe F, Dick JE. 2006. Targeting of CD44 eradicates human acute myeloid leukemic stem cells. Nature Medicine 12(10):1167-1174. (Pubitemid 44527352)
32. Jones DL, Wagers AJ. 2008. No place like home: Anatomy and function of the stem cell niche. Nature Reviews Molecular Cell Biology 9(1):11-21.
33. Kaplan RN, Riba RD, Zacharoulis S, Bramley AH, Vincent L, Costa C, MacDonald DD, Jin DK, Shido K, Kerns SA, Zhu Z, Hicklin D, Wu Y, Port JL, Altorki N, Port ER, Ruggero D, Shmelkov SV, Jensen KK, Rafii S, Lyden D. 2005. VEGFR1- positive haematopoietic bone marrow progenitors initiate the pre-metastatic niche. Nature 438(7069):820-827.
34. Kiel MJ, Yilmaz OH, Iwashita T, Yilmaz OH, Terhorst C, Morrison SJ. 2005. SLAM family receptors distinguish hematopoietic stem and progenitor cells and reveal endothelial niches for stem cells. Cell 121(7):1109-1121.
35. Kiger AA, Jones DL, Schulz C, Rogers MB, Fuller MT. 2001. Stem cell self-renewal specified by JAK-STAT activation in response to a support cell cue. Science 294(5551):2542-2545.
36. Kimble JE, White JG. 1981. On the control of germ cell development in Caenorhabditis elegans. Developmental Biology 81(2):208-219.
37. Krause DS, Lazarides K, von Andrian UH, Van Etten RA. 2006. Requirement for CD44 in homing and engraftment of BCRABL- expressing leukemic stem cells. Nature Medicine 12(10): 1175-1180.
38. Kvinlaug BT, Huntly BJ. 2007. Targeting cancer stem cells. Expert Opinion on Therapeutic Targets 11(7):915-927.
39. Lapidot T, Sirard C, Vormoor J, Murdoch B, Hoang T, Caceres- Cortes J, Minden M, Paterson B, Caligiuri MA, Dick JE. 1994. A cell initiating human acute myeloid leukaemia after transplantation into SCID mice. Nature Letters 367(6464):645-648.
40. Lee CG, Heijn M, di Tomaso E, Griffon-Etienne G, Ancukiewicz M, Koike C, Park KR, Ferrara N, Jain RK, Suit HD, Boucher Y. 2000. Anti-vascular endothelial growth factor treatment augments tumor radiation response under normoxic or hypoxic conditions. Cancer Research 60(19):5565-5570.
41. Li J, Huang S, Armstrong EA, Fowler JF, Harari PM. 2005. Angiogenesis and radiation response modulation after vascular endothelial growth factor receptor-2 (VEGFR2) blockade. International Journal of Radiation Oncology, Biology, Physics 62(5):1477-1485.
42. Li L, Xie T. 2005. Stem cell niche: structure and function. Annual Review of Cell and Developmental Biology 21:605-631.
43. Lobo NA, Shimono Y, Qian D, Clarke MF. 2008. The biology of cancer stem cells. Stem Cells 1:675-699.
44. Mani SA, Guo W, Liao MJ, Eaton EN, Ayyanan A, Zhou AY, Brooks M, Reinhard F, Zhang CC, ShipitsinM, Campbell LL, Polyak K, Brisken C, Yang J, Weinberg RA. 2008. The epithelial-mesenchymal transition generates cells with properties of stem cells. Cell 133(4):704-715.
45. Maynard S, Swistowska AM, Lee, JW, Liu Y, Liu ST, Bettencourt Da Cruz A, Rao M, de Souza-Pinto NC, Zeng X, Bohr VA. 2008. Human embryonic stem cells have enhanced repair of multiple forms of DNA damage. Stem Cells 26:2266-2274.
46. Miyamoto K, Araki KY, Naka K, Arai F, Takubo K, Yamazaki S, Matsuoka S, Miyamoto T, Ito K, Ohmura M, Chen C, Hosokawa K, Nakauchi H, Nakayama K, Nakayama KI, Harada M, Motoyama N, Suda T, Hirao A. 2007. Foxo3a is essential for maintenance of the hematopoietic stem cell pool. Cell Stem Cell 1(1):101-112.
47. Palmer TD, Willhoite AR, Gage FH. 2000. Vascular niche for adult hippocampal neurogenesis. The Journal of Comparative Neurology 425(4):479-494.
48. Powell S, McMillan TJ. 1990. DNA damage and repair following treatment with ionizing radiation. Radiotherapy and Oncology 19(2):95-108.
49. Raaijmakers MHGP, de Grouw EPLM, Heuver LHH, van der Reijden BA, Jansen JH, Scheper RJ, Scheffer GL, de Witte TJM, Raymakers RAP. 2005. Breast cancer resistance protein in drug resistance of primitive CD34+38-cells in acute myeloid leukemia. Clinical Cancer Research 11(6):2436-2444.
50. Rich JN, Bao S. 2007. Chemotherapy and cancer stem cells. Cell Stem Cell 1(4):353-355.
51. Riquelme PA, Drapeau E, Doetsch F. 2008. Brain microecologies: neural stem cell niches in the adult mammalian brain. Philosophical Transactions of the Royal Society of London, B: International Journal of Biological Sciences 363(1489):123-137.
52. Saretzki G, Armstrong L, Leake A, Lako M, von Zglinicki T. 2004. Stress defense in murine ESCs is superior to that of various differentiated murine cells. Stem Cells 22:962-971.
53. Schinkel AH, Smit JJM, van Tellingen O, Beijen JH, Wagenaar E, van Deemter L, Mol CAAM, van der Valk MA, Robanus- Maandag EC, te Riele HPJ, Berns AJM, Borst P. 1994. Disruption of the mouse mdr1a P-Glycoprotein gene leads to a deficiency in the blood-brain barrier and to increased sensitivity to drugs. Cell 77:491-502.
54. Schofield R. 1978. The relationship between the spleen colonyforming cell and the haemopoietic stem cell. Blood Cells 4(1-2):7-25.
55. Singh SK, Hawkins C, Clarke ID, Squire JA, Bayani J, Hide T, Henkelman RM, Cusimano MD, Dirks PB. 2004. Identification of human brain tumor initiating cells. Nature 432(7015): 396-401.
56. Sipkins DA, Wei X, Wu JW, Runnels JM, Cǒté D, Means TK, Luster AD, Scadden DT, Lin CP. 2005. In vivo imaging of specialized bone marrow endothelial microdomains for tumor engraftment. Nature 435(7044):969-973.
57. Smith J, Ladi E, Mayer-Proschel M, Noble M. 2000. Redox state is a central modulator of the balance between self-renewal and differentiation in a dividing glial precursor cell. Proceedings of the National Academy of Sciences USA 97(18):10032-10037.
58. Sneddon JB, Werb Z. 2007. Location, location, location: The cancer stem cell niche. Cell Stem Cell 1(6):607-611.
59. Song X, Xie T. 2002. DE-cadherin-mediated cell adhesion is essential for maintaining somatic stem cells in the Drosophila ovary. Proceedings of the National Academy of Sciences USA 99(23):14813-14818.
60. Song X, Zhu CH, Doan C, Xie T. 2002. Germline stem cells anchored by adherens junctions in the Drosophila ovary niches. Science 296(5574):1855-1857.
61. Tichy ED, Stambrook PJ. 2008. DNA repair in murine ESCs and differentiated cells. Exp erimental Cell Research 314:1929-1936.
62. Tothova Z, Kollipara R, Huntly BJ, Lee BH, Castrillon DH, Cullen DE, McDowell EP, Lazo-Kallanian S, Williams IR, Sears C, Armstrong SA, Passegué E, DePinho RA, Gilliland DG. 2007. FoxOs are critical mediators of hematopoietic stem cell resistance to physiologic oxidative stress. Cell 128(2):325-339.
63. Tsatmali M, Walcott EC, Crossin KL. 2005. Newborn neurons acquire high levels of reactive oxygen species and increased mitochondrial proteins upon differentiation from progenitors. Brain Research 1040(1-2):137-150.
64. Tulina N, Matunis E. 2001. Control of stem cell self-renewal in Drosophila spermatogenesis by JAK-STAT signaling. Science 294(5551):2546-2549.
65. Tumbar T, Guasch G, Greco V, Blanpain C, Lowry WE, Rendl M, Fuchs E. 2004. Defining the epithelial Stem Cell niche in skin. Science 16; 303(5656):359-363. (Pubitemid 38095773)
66. Vaish M. 2007. Mismatch repair deficiences trasnforming stem cells into cancer stem cells and therapeutic implications. Molecular Cancer 6:26.
67. Visvader JE, Lindeman GJ. 2008. Cancer stem cells in solid tumors: accumulating evidence and unresolved questions. Nature Reviews Cancer 8:755.
68. Vlashi E, Kim K, Lagadec C, Donna LD, McDonald JT, Eghbali M, Sayre JW, Stefani E, McBride W, Pajonk F. 2009. In vivo imaging, tracking, and targeting of cancer stem cells. Journal of the National Cancer Institute 101(5):350-359.
69. Vredenburgh JJ, Desjardins A, Herndon JE 2nd, Dowell JM, Reardon DA, Quinn JA, Rich JN, Sathornsumetee S, Gururangan S, Wagner M, Bigner DD, Friedman AH, Friedman HS. 2007. Phase II trial of bevacizumab and irinotecan in recurrent malignant glioma. Clinical Cancer Research 13(4):1253-1259.
70. Ward JF. 1985. Biochemistry of DNA lesions. Radiation Research 8:S103-S111.
71. Wright DE, Wagers AJ, Gulati AP, Johnson FL, Weissman IL. 2001. Physiological migration of hematopoietic stem and progenitor cells. Science 294(5548):1933-1936.
72. Xie T, Spradling AC. 2000. A niche maintaining germ line stem cells in the Drosophila ovary. Science 290(5490): 328-330.
73. Yamashita YM, Jones DL, Fuller MT. 2003. Orientation of asymmetric stem cell division by the APC tumor suppressor and centrosome. Science 301(5639):1547-1550.
74. Yang FC, Chen S, Clegg T, Li X, Morgan T, Estwick SA, Yuan J, Khalaf W, Burgin S, Travers J, Parada LF, Ingram DA, Clapp DW. 2006. Nf1+/7 mast cells induce neurofibroma like phenotypes through secreted TGF-beta signaling. Human Molecular Genetics 15(16):2421-2437.
75. Yilmaz OH, Valdez R, Theisen BK, Guo W, Ferguson DO, Wu H, Morrison SJ. 2006. Pten dependence distinguishes haematopoietic stem cells from leukaemia-initiating cells. Nature 441(7092):475-482. (Pubitemid 44050144)
76. Zhang J, Niu C, Ye L, Huang H, He X, Tong WG, Ross J, Haug J, Johnson T, Feng JQ, Harris S, Wiedemann LM, Mishina Y, Li L. 2003. Identification of the haematopoietic stem cell niche and control of the niche size. Nature 425(6960):836-841.
77. Zhou S, Schuetz JD, Bunting KD, Colapietro AM, Sampath J, Morris JJ, Lagutina I, Grosveld GC, Osawa M, Nakauchi H, Sorrentino BP. 2001. The ABC transporter Bcrp1/ABCG2 is expressed in a wide variety of stem cells and is a molecular determinant of the side-population phenotype. Nature Medicine 7(7):1028-1034.
78. Zhu Y, Ghosh P, Charnay P, Burns DK, Parada LF. 2002. Neurofibromas in NF1: Schwann cell origin and role of tumor environment. Science 296(5569):920-922.